1. AstraZeneca pays Sobi $95M for priority review voucher — Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study — Retrophin sinks as drug “Pharma Bro” Martin Shkreli co-invented fails — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Biofrontera

Anonymous board for Biofrontera

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    1
    Views:
    420
  2. anonymous
    Replies:
    7
    Views:
    1,025
  3. anonymous
    Replies:
    7
    Views:
    958
  4. anonymous
    Replies:
    5
    Views:
    1,819
  5. anonymous
    Replies:
    3
    Views:
    1,423
  6. anonymous
    Replies:
    31
    Views:
    7,568
  7. Biofrontera's expansion
    Replies:
    17
    Views:
    3,659
  8. anonymous
    Replies:
    2
    Views:
    986
  9. anonymous
    Replies:
    5
    Views:
    2,062
  10. STAY CLEAR
    Replies:
    1
    Views:
    1,394

Thread Display Options

Loading...